aaronuconn
Well-known member
I always appreciate your input on things. This weekend, I'm going thru and finalize formula releases for Q4 of this year and Q1 of next year and compared your above to the prostate formula that I have designed. Some of it is the same and I have quite a few things included that aren't on your list.
For CardioAid, it is predominantly in an oil form so it would have to be softgel to go with one of the higher percentages; they do make a powder version but the percentages aren't as good and the price to use it is very high for what it is imo.
For ApresFlex, is there a particular reason you suggested this one as a Boswellin source? It is more commonly associated with joint health and regardless of use, I personally prefer Sabinsa's Super Boswellin. If you prefer pm's, I'd love to hear your reasoning if you do prefer ApresFlex or if you think of them as interchangeable.
They very well may be interchangeable. My reason is that ApresFlex (20% AKBA) was specifically shown to be better at 5-lipoxygenase inhibition then a similar Boswellin source (30% AKBA), and there’s some interesting early research into 5-LOX inhibition and prostate cancer. Always good to be cautious of cell studies of course.
Aflapin/ApresFlex vs 5-Loxin: Invalid Link Removed
Invalid Link Removed
Invalid Link Removed
Invalid Link Removed